Warfarin pharmacogenetics in patients with heart valve replacement

Author
Cagatay, Penbe
SÜSLEYİCİ, BELGİN
Atas, Halil
Ciftci, Cavlan
KARAALP, ATİLA
Bezci, Kivanc
Cevik, Mehtap
Akdeniz, Cansu Selcan
Canbolat, Ismail Polat
Yurdakul, Selen
SÜNBÜL, MURAT
Metadata
Show full item record
Abstract
Background: Warfarin treatment is crucial to prevent thrombolytic complications after the heart valve replacement (HVR) operation. Our purpose was to investigate the prevalence of CYP2C9 *2 and *3 gene polymorphisms, which are essential in warfarin metabolism in patients with and without HVR surgery prescribed with warfarin.
URI
http://hdl.handle.net/20.500.12627/3684
https://doi.org/10.1016/j.genrep.2020.100769
Collections